AEON Biopharma, Inc.

Historical 13F Holders

Symbol
AEON
CUSIP
00791X100
All holders as of
Q4 2024
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00791X100 since 12/18/2024, newest first.

Filer % of Class Filed
Polar Asset Management Partners Inc. 13G/A Amendment 2 0% 5/15/2025
Event 3/31/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A Amendment 1 4.1% 5/15/2025
Event 3/31/2025
S.H.N. Financial Investments Ltd. 13G/A Amendment 1 0% 5/15/2025
Event 3/31/2025
Robert J Palmisano 13D/A Amendment 1
5.7% 3/7/2025
Event 7/25/2024
Polar Asset Management Partners Inc. 13G/A Amendment 1 6.9% 2/14/2025
Event 12/31/2024
Blue Owl Capital Holdings LP 13G/A Amendment 1 3.8% 2/14/2025
Event 12/31/2024
Robert J Palmisano 13D
5.7% 1/22/2025
Event 7/25/2024
S.H.N. Financial Investments Ltd. 13G 6.0% 1/13/2025
Event 1/6/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G 10.0% 1/13/2025
Event 1/6/2025
Bigger Capital Fund L P 13G
6.1% 1/8/2025
Event 1/6/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 38 8.88 M $4.80 M
2024 Q3 32 9.57 M $10.1 M
2024 Q2 28 9.43 M $8.73 M
2024 Q1 31 9.52 M $104 M
2023 Q4 25 8.69 M $57.0 M
2023 Q3 16 4.75 M $25.9 M